XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Product revenue, net $ 9,698 $ 0 $ 10,849 $ 0
Cost of goods sold 3,058 0 3,482 0
Gross profit 6,640 0 7,367 0
Operating expenses:        
Research and development 42,425 175,977 98,495 216,980
Selling, general and administrative 124,802 23,231 220,403 36,689
Total operating expenses 167,227 199,208 318,898 253,669
Loss from operations (160,587) (199,208) (311,531) (253,669)
Other income (expense):        
Interest expense (172) 0 (227) 0
Non-cash interest expense on mandatorily redeemable preferred shares (6,993) (3,955) (12,554) (3,955)
Non-cash interest expense on liability related to sale of future royalties (11,570) (5,155) (19,995) (11,972)
Change in fair value of derivative liability 650 (1,263) (5,131) (1,263)
Loss from equity method investment (1,485) (1,415) (2,865) (2,315)
Other (119) (16) (216) (33)
Total other expense, net (19,689) (11,804) (40,988) (19,538)
Loss before provision for income taxes (180,276) (211,012) (352,519) (273,207)
Provision for income taxes 658 58 1,352 167
Net loss and comprehensive loss $ (180,934) $ (211,070) $ (353,871) $ (273,374)
Net loss per share - basic and diluted (in dollars per share) $ (3.08) $ (4.67) $ (6.15) $ (6.11)
Weighted average common shares outstanding - basic and diluted (shares) 58,742,329 45,226,434 57,577,384 44,736,971